Study Finds That Ebola Vaccine Is Safe and Stimulates Strong Immune Response

November 18, 2015

(Medical Xpress) – A clinical trial of a new Ebola vaccine (ChAd3-EBO-Z) that resulted from an unprecedented global consortium assembled at the behest of the World Health Organization has found that it is well tolerated and stimulates strong immune responses in adults in Mali, West Africa and in the US, according to a study published in the latest issue of the journal Lancet Infectious Disease.